Your browser doesn't support javascript.
loading
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids.
Guidetti, Lorenzo; Castelli, Riccardo; Scalvini, Laura; Ferlenghi, Francesca; Corrado, Miriam; Giorgio, Carmine; Tognolini, Massimiliano; Lodola, Alessio.
Afiliación
  • Guidetti L; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Castelli R; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Scalvini L; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Ferlenghi F; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Corrado M; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Giorgio C; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Tognolini M; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
  • Lodola A; Department of Food and Drug, University of Parma, I-43124 Parma, Italy.
Pharmaceuticals (Basel) ; 15(2)2022 Jan 24.
Article en En | MEDLINE | ID: mdl-35215250
The role of the Eph-ephrin system in the etiology of pathological conditions has been consolidated throughout the years. In this context, approaches directed against this signaling system, intended to modulate its activity, can be strategic therapeutic opportunities. Currently, the most promising class of compounds able to interfere with the Eph receptor-ephrin protein interaction is composed of synthetic derivatives of bile acids. In the present review, we summarize the progresses achieved, in terms of chemical expansions and structure-activity relationships, both in the steroidal core and the terminal carboxylic acid group, along with the pharmacological characterization for the most promising Eph-ephrin antagonists in in vivo settings.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia